While the science of pharmacogenomics has been around for years, its popularity is starting to pick up steam as ...
Read more
Can COVID-19 testing be made more sustainable during prolonged uncertainty?
In September 2021, Delta persists as the most prevalent variant worldwide due to its high infectivity, causing surges in COVID-19 cases to the point where some areas are reopening mass testing centres. As long as COVID-19 continues to defy expectations and predictions, testing will play a key role in managing the virus - whether it’s for re-introducing activities that provide a sense of normalcy or for the surveillance of emerging variants. With some local governments incorporating mandatory testing requirements into their re-opening strategies, there is growing concern about the availability and supply-chain resilience in order to access testing reagents and supplies to support another spike in demand.
Read moreThe BiosearchTech Blog
3.2 billion people across 106 countries and territories, live in areas at risk of malaria transmission. The serious and ...
Read more
Topics: Genomics, IntelliQube, Genotyping, Malaria
"Put in your samples, put in your assays, hit the green button and go!" It seems simple because it really is that ...
Read more
Topics: IntelliQube, SLAS2017
It seems everyone wants to do more with less, and automate the process as well. But this can cause a number of ...
Read more
Topics: Genomics, Douglas Scientific, IntelliQube, qPCR